Dataset Information


Clinical Trials of Antiangiogenesis Therapy on Gastric Cancer.

ABSTRACT: Both malignant tumor growth and metastasis are dependent upon angiogenesis, a process of new blood vessel formation. Inhibition of this process by specific inhibitors might be able to control tumor growth and metastasis. Therefore, antiangiogenesis thereapy is considered a promising strategy and being studied worldwide. A wide variety of angiogenesis inhibitors have been identified and some of them are under clinical trials in the advanced patients with cancer including gastric cancer. This review summarizes the development and progress of angiogenesis inhibitors in recent decades, and discusses the future direction of antiangiogenesis research, and the potential antiangiogenic agents which are most likely to be translated into standard treatment for gastrointestinal cancer patients either alone or combined with other therapies.


PROVIDER: S-EPMC5154210 | BioStudies | 2008-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC2637411 | BioStudies
2011-01-01 | S-EPMC3070759 | BioStudies
2018-01-01 | S-EPMC6234506 | BioStudies
2013-01-01 | S-EPMC3816513 | BioStudies
2019-01-01 | S-EPMC6468754 | BioStudies
2012-01-01 | S-EPMC3481559 | BioStudies
2007-01-01 | S-EPMC1931565 | BioStudies
1000-01-01 | S-EPMC2821752 | BioStudies
2014-01-01 | S-EPMC4061618 | BioStudies
2003-01-01 | S-EPMC2394225 | BioStudies